conect4children's Podcast

We're back with c4c podcasts! In this episode, Mark Turner, Sabah Attar and Ricardo Fernandes take us through the transition from a publicly-funded project to a stand-alone organization.

We're back with c4c podcasts! In this episode, Mark Turner, Begonya Nafria, Donato Bonifazi, Ricardo Fernandes discuss the Challenges and Opportunities in Pediatrics Clinical Research, - Digital Innovation & Transformation. Enjoy!

Welcome back to this new c4c podcast episode! Today, we are joined by Pirkko Lepola, Executive Secretary of Finnish pediatric research network, c4c National Hub Helsinki University Hospital, to talk about the ethical principles in paediatric clinical trials. What are the current rules? How to make sure to apply children's rights? Listen to this episode, we hope you enjoy it!

Welcome back to this new c4c podcast episode! Today, we are joined by Pirkko Lepola, Executive Secretary of Finnish pediatric research network, c4c National Hub Helsinki University Hospital, to talk about the ethical principles in paediatric clinical trials. What are the current rules? How to set up a paediatric clinical trials by following these rules? How can c4c support this pro

Welcome to another episode of the c4c podcast! Today, we are joined by Eva Degraeuwe, Core team Belgian National hub, Founder YIC, Tessa van der Geest Project Manager Pedmed-NL and Mark Turner University of Liverpool Co-coordinator c4c to talk about the Young Investigators Community! What is the Young Investigators Community? c4c has established the Young Investigators Community to

In this podcast episode, we are joined by Professor Franz Schaefer, Head of Pediatric Nephrology at Heidelberg University Hospital, and Saskia de Wildt, Professor of Clinical Pharmacology and pediatric intensivist at Radboud University & Erasmus MC Sophia Children's Hospital. Franz and Saskia are both involved in the c4c methodology experts’ groups, that bring together expert

Kawasaki disease is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.The clinical trial “KD-CAAP” studies the effectiveness of adding a new element to the standard treatment for this disease. What are the hopes for Kawasaki disease treatment and patients? Listen to our podcast with Prof. Paul Brogan, joined chief investigator

Kawasaki disease, also known as Kawasaki syndrome, is an acute febrile illness of unknown cause that primarily affects children younger than 5 years of age.KD-CAAP proof of viability study assesses the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease.Why is it important to improve paediatric patient’s lives? How is c4c supporting this study

conect4children podcast is back with a new episode around Science communication! Why is Science communication essential nowadays, especially for an European Network as conect4children? How to efficiently communicate science? How to overcome the challenges around fake news? Join our Claudio Fracasso, Pediatric Clinical Director in Pfizer Pediatric Center of Excellence, and Lindsey H

In today’s episode, we’re exploring what CasperCF study is. What’s the objective of this study? Why is it important for children?Listen to the full episode with Jacob Bradbury, Graduate research assistant at Exeter University!